Fidia’s Hyaluronic Acid from fermentation has been recently granted the Certificate of Suitability…
Fidia farmaceutici today announced the positive preliminary results from an open-label, single-arm,…

Fidia Pharma Egypt is headquartered in Cairo, with a sales team of 45 people and is market leader of IAHA products

Fidia Farmaceutici announces the expansion of its affiliate network, with the recent opening of…

Unique formulation with a bioactive curcumin extract Bio-Curcumin Curcugreen™ (100% natural turmeric), glucosamine hydrochloride and chondroitin sulfate.

Fidia Farmaceutici is introducing CartiJoint™ FORTE, its first product in the dietary supplement…

First product in the regenerative medicine category

FLORHAM PARK, N.J.--(BUSINESS WIRE)-- Fidia, a world leader in the research, development, and…

The “ Sleep&Psyche” project dedicated to psychiatry specialists

Findings from recent studies have demonstrated the close relationship between disruption of the sleep-wake cycle and chronic conditions

Thanks to the contribution of Fidia Farmaceutici, the 2019 edition of the Sleep& Psyche Project…


Find out more about Fidia’s product portfolio:

Go to the website

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint care
- ophthalmology
- active wound care
- neuroscience
- aesthetic medicine